Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series
- PMID: 32795482
- PMCID: PMC7419246
- DOI: 10.1016/j.jinf.2020.08.010
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series
Keywords: COVID-19; Calprotectin; GDF-15; Prognosis.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interests.
Comment in
-
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.016. Epub 2020 Nov 17. J Infect. 2021. PMID: 33217473 Free PMC article. No abstract available.
Comment on
-
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.J Infect. 2020 Jun;80(6):646-655. doi: 10.1016/j.jinf.2020.03.035. Epub 2020 Apr 8. J Infect. 2020. PMID: 32277967 Free PMC article.
References
-
- Bohn M.K., Lippi G., Horvath A., Sethi S., Koch D., Ferrari M. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020;58:1037–1052. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical